The power of our people The power of our people Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity.
Performance Indicators Performance Indicators Performance indicators concerning Environment Health and Safety (EHS) are summarized here.
Ruminant parasite control in a nutshell Ruminant parasite control in a nutshell An exclusive drug-based approach to fight worms is dying. Dr. Ray Kaplan, from Georgia University, explains five things you need to know.
Edda Dankmeyer Edda Dankmeyer Edda Dankmeyer leads Sustainable Development Communications and explains how sustainable development can bea key differentiator for the company.
Co-creation with Communities Co-creation with Communities Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.
Green Chemistry Green Chemistry Green Chemistry is critical for us as it balance the long-term sustainability of business, society, and the environment.
Nagoya Protocol Nagoya Protocol At Boehringer Ingelheim, environmental consciousness and protection are priorities in everything we do.
Advancing green chemistry for more sustainable medicines Advancing green chemistry for more sustainable medicines By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint.
Making-more-health-together-2021 Making-more-health-together-2021 1,200 participants from around the world join virtual convention on November 11-12
More Health Overview More Health Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Our Health and Safety initiative - BE SAFE Our Health and Safety initiative - BE SAFE Health and safety are of great importance to Boehringer Ingelheim.
Circular economy Circular economy Boehringer Ingelheim strives to use resources for as long as possible, process them for reuse or recycle them.
More Potential Overview More Potential Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Our Stories Our Stories Find out more about us by reading our stories. Below are the latest press releases, news stories, and more from our family around the world.
Health for all: How can we contribute to inclusive access? Health for all: How can we contribute to inclusive access? What drives us to improve the health of humans and animals worldwide
More health in vulnerable communities More health in vulnerable communities In an era of globalization and social connectivity, one-dimensional solutions often do not work anymore. Complex challenges need complex solutions.
The impact of carbon reduction projects The impact of carbon reduction projects Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.
sustainably fighting rabies info hub sustainably fighting rabies info hub Did you know that every nine minutes, rabies takes a human life? Find out how we support the elimination of this deadly disease.
New spesolimab data show significant improvement in GPP flares New spesolimab data show significant improvement in GPP flares New spesolimab data show significant improvement in GPP flares
new_analysis_nintedanib_SSc_ILD new_analysis_nintedanib_SSc_ILD Interim analysis results support long term treatment with nintedanib in SSc-ILD patients
World Recycling Day: Closing the Loop World Recycling Day: Closing the Loop Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Spesolimab prevents GPP flares Spesolimab prevents GPP flares Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Our culture Our culture Our culture reflects who we are and is reflected in Our FOCUS and strong belief in Diversity, Equity and Inclusion as well as Sustainable Development.
FDA approves Jardiance treatment chronic kidney disease FDA approves Jardiance treatment chronic kidney disease U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease